Allergan rolls out Viberzi after DEA delay; Sun Pharma unloads Ohio manufacturing unit;

@FiercePharma: Veterinarians debate necessity of dog flu vaccines from Merck and Zoetis. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: ICYMI Friday: NICE backs Astellas' Xtandi in pre-chemo patients, but J&J's Zytiga isn't so lucky. Article | Follow @CarlyHFierce

> Allergan ($AGN) launched its irritable bowel syndrome drug Viberzi in the U.S.; the drug won FDA approval earlier this year, but it's been waiting on a scheduling review by the Drug Enforcement Agency. Report

> India-based Sun Pharmaceutical is selling off its manufacturing unit in Bryan, OH, to Nostrum Laboratories. Report

> Alnylam ($ALNY) is planning final trials for ALN-CC5--a paroxysmal nocturnal hemoglobinuria candidate that would compete with Alexion's ($ALXN) pricey Soliris--for 2017. Report

Medical Device News

@FierceMedDev: ICYMI: Bloomberg: Embattled Theranos CEO continues to beat the 'transparency' drum. Report | Follow @FierceMedDev

@EmilyWFierce: Lab experts lash out at FDA move to beef up regulation of lab-developed tests. Article | Follow @EmilyWFierce

> St. Jude touts new forms of neurostimulation at Neuromodulation Society meeting. More

> WuXi leads $30M for startup to back Dx for personalized cardio, oncology drug regimens. Article

> App-based glucose monitor implant startup Senseonics reverse-merges to go public in anticipation of CE mark. Story

Biotech News

@FierceBiotech: ICYMI Friday: AstraZeneca looks to bag Imbruvica rival in $5B-plus Acerta buyout: Report. More | Follow @FierceBiotech

@JohnCFierce: Mitsubishi Tanabe backs Akebia PhIII with a $350M Asian deal for vadadustat. Report | Follow @JohnCFierce

@DamianFierce: The 2015 Biotech IPO Boom, in Requiem. Watch | Follow @DamianFierce

> Roche wins FDA approval for a new lung cancer drug. News

> Another day, another biotech scheme from Martin Shkreli, the master of biopharma disaster. Editor's corner

> $37.5M in hand, Termeer-backed X4 maps a fast pace on cancer immunotherapy R&D. Article

Pharma Marketing News

> Roche challenges hometown rival Novartis with new targeted lung-cancer med Alecensa. Item

> Shire finally gets Baxalta to the deal-talks table. Article

> Novo Nordisk eyes stepped-up diabetes care in 'beyond the pill' deal with IBM Watson. Story

> Pharma comics partner Medikidz aims to be a child health superhero. Report

> BMS' Opdivo repeats, new flu ads join list of top pharma ad spending for November. More

Animal Health News

> Cornell scientists create first litter of puppies through in vitro fertilization. News

> Report: Antibiotic sales for food animals still on the rise, despite FDA restrictions. Item

> U.K.-based Genus teams with U.S. scientists to create pigs resistant to deadly virus. Story

> Veterinarians debate necessity of dog flu vaccines from Merck and Zoetis. More

> Lilly separates animal health manufacturing but insists it's not prepping a spinoff. Article

Biotech IT News

> GoBalto lands global site activation software deal with Icon. More

> Academics snag EU cash for 3-D genomics project. Report

> SAP makes pitch for precision medicine market with a pair of products. Item

> Analyst: Use of tech to streamline clinical trials 'still early in its adoption cycle.' Story

> Illumina invests in CRISPR gene editing software player. Article

And Finally... Dog owners are wondering whether to vaccinate their dogs against canine influenza virus H3N. More (sub. req.)